Cardinal Health Reports Strong Q1 Fiscal 2027 Results and Raises Annual EPS Guidance
Cardinal Health (NYSE: CAH) reported robust first-quarter fiscal year 2027 results, characterized by a 5% revenue increase to $67.5 billion and a significant jump in non-GAAP diluted earnings per share (EPS) of 28% to $3.26. The company's performance was primarily driven by its Pharmaceutical and Specialty Solutions segment, which saw a 6% revenue rise fueled by brand and specialty pharmaceutical sales. Following the strong quarterly performance, Cardinal Health raised its full-year fiscal 2027 non-GAAP EPS guidance to a range of $12.80 to $13.00. The company also successfully completed a $500 million share repurchase program during the quarter, reflecting disciplined capital allocation and strong cash flow generation.
Tickers: $CAH
Topics: earnings per share guidance raise revenue growth share repurchase
Read the full article at PR Newswire
Part of the story Cardinal Health Reports Strong Q1 Fiscal 2027 Results and Raises Annual EPS Guidance (27 articles)